AUG 01, 2021 9:32 AM PDT

New Compound Halts Neurodegeneration in Alzheimer's

WRITTEN BY: Annie Lennon

Chemists have synthesized new compounds that can halt neurodegeneration linked to Alzheimer’s and other neurological conditions. The study was published in the European Journal of Medicinal Chemistry by researchers from the Russian Academy of Sciences. 

Alzheimer’s disease is characterized by a build-up of amyloid plaques in the brain. This build-up reduces synaptic communication, which results in the cognitive symptoms associated with Alzheimer’s. 

Previous research has found that people with Alzheimer’s tend to have low levels of heat shock proteins (HSPs), which are key for preventing protein misfolding and aggregation. Hsp90 inhibitors, in particular, are thought to regulate the activity of the transcription factor heat shock factor (HSF-1), as well as Hsp70, and thus protect against the over-accumulation of harmful proteins.

“Our compounds activate the synthesis of specific heat shock proteins and cause their accumulation in the cell,” said Irina Utepova, one of the researchers behind the study. 

“Proteins of this type make it possible to protect neuronal tissue from an excess of toxic amyloids and to protect cells from various types of stress, including proteotoxic stress characteristic of neurodegenerative diseases,” she continued. 

For the study, the researchers synthesized a group of pyrrolyl- and indolylaznes via photocatalysis that cause heat shock proteins to accumulate. In cells models of both Alzheimer's disease and traumatic brain injury, they found that the compounds were able to increase the survival of neuronal cells. 

The researchers then tested the most effective of these compounds on live rat tissues with secondary injuries from traumatic brain injury. Use of the drug, say the researchers, prevented the appearance of movement disorders and degeneration among hippocampal neurons. 

The researchers are currently conducting further research on the mechanism of action for their new compounds in preparation for preclinical tests. 

 

Sources: European Journal of Medicinal ChemistryPMCBiomed Research InternationalNeuroscience News

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUL 15, 2021
Drug Discovery & Development
The genomics of high blood pressure - a road to the future of treatment
JUL 15, 2021
The genomics of high blood pressure - a road to the future of treatment
The human heart begins to beat in utero in the early weeks of development and continues throughout life. In an average l ...
JUL 15, 2021
Cannabis Sciences
Cannabis Terpenes Provide Pain Relief in Mice
JUL 15, 2021
Cannabis Terpenes Provide Pain Relief in Mice
Cannabis terpenes, the part of cannabis plants responsible for its smell and taste, may be able to relieve pain both by ...
AUG 01, 2021
Drug Discovery & Development
Berry Compound Reverses Parkinson's in Mice
AUG 01, 2021
Berry Compound Reverses Parkinson's in Mice
A naturally-occurring compound called farnesol found in berries and other fruits prevents and reverses Parkinson's-a ...
AUG 20, 2021
Health & Medicine
Nanotechnology and Management of COVID-19- A Promising Future?
AUG 20, 2021
Nanotechnology and Management of COVID-19- A Promising Future?
The rate of viral spread and high mortality demanded a quick response to COVID-19.  As such, pre-existing drugs wer ...
SEP 07, 2021
Drug Discovery & Development
A giant step in treating growth disorders in children.
SEP 07, 2021
A giant step in treating growth disorders in children.
Hormone production and release is important in individuals of all ages but is especially important for children as hormo ...
SEP 24, 2021
Drug Discovery & Development
WHO Recommends Antibody Treatment for High Risk COVID-19 Patients
SEP 24, 2021
WHO Recommends Antibody Treatment for High Risk COVID-19 Patients
The World Health Organization (WHO) has recommended a combination of two antibody treatments for patients at risk of adv ...
Loading Comments...